Archive · 3 Oct 2025
Ozempic vs Mounjaro: Weight Loss Drug Comparison
Imagine your body has a sugar problem, and you need help controlling it and losing some weight.
Ozempic and Mounjaro are like weekly shots that help with both.
They work by making you feel less hungry, so you eat less.
Mounjaro is like a super version that targets two paths to help your body process sugar.
Studies suggest Mounjaro might be better for weight loss, but both can have side effects like tummy troubles.
Doctors in India are using both drugs to help their patients, but patients should consult a doctor before using.
Ozempic and Mounjaro are weekly injections for type 2 diabetes and weight loss.
Mounjaro received approval in India in June 2024; Ozempic in September 2024.
Both drugs suppress appetite, helping with weight loss.
Mounjaro acts on two hormone pathways (GIP & GLP-1); Ozempic on one (GLP-1).
Mounjaro may be more effective for weight loss, but both have potential side effects.
- Who
- Patients with type 2 diabetes and obese individuals.
- What
- A comparison of Ozempic and Mounjaro, weight loss drugs.
- When
- Ozempic approved in September 2024. Mounjaro approved earlier in 2024.
- Where
- India
- Why
- To help people manage diabetes and lose weight.
- Ozempic Approval
- Approved in India, launch date pending.
- Mounjaro Approval
- Approved in India earlier in 2024
- Primary Function
- Type 2 diabetes treatment & weight loss.
- Mechanism
- Weekly injections suppressing appetite.
- Mounjaro Action
- Dual action: GIP and GLP-1 pathways.
- Ozempic Action
- Targets GLP-1 pathway only.
- Potential Side Effects
- Nausea, vomiting, diarrhea, constipation, bloating.
- Mounjaro Cost
- Rs 14,000 to Rs 17,500 per month in India